Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer by Enrica Marmonti, Jacqueline Oliva-Ramirez, Cara Haymaker

Get full text

Spatial modelling of the tumor microenvironment from multiplex immunofluorescence images: methods and applications by Gayatri Kumar, Renganayaki Krishna Pandurengan, Edwin Roger Parra, Kasthuri Kannan, Cara Haymaker

Get full text

A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1 by Patrick Hwu, Cara Haymaker, Chantale Bernatchez, Marc Uemura, Adi Diab, Natalie McQuail, Elizabeth Sirmans, Faisal Faˈak, Courtney W. Hudgens, Lydia Barbara, Jonathan L. Curry, Michael T. Tetzlaff

Get full text

Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer by Edwin Roger Parra, Jiexin Zhang, Mei Jiang, Auriole Tamegnon, Renganayaki Krishna Pandurengan, Carmen Behrens, Luisa Solis, Cara Haymaker, John Victor Heymach, Cesar Moran, Jack J. Lee, Don Gibbons, Ignacio Ivan Wistuba

Get full text

Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profiles by Shan He, Matthew M. Gubin, Hind Rafei, Rafet Basar, Merve Dede, Xianli Jiang, Qingnan Liang, Yukun Tan, Kunhee Kim, Maura L. Gillison, Katayoun Rezvani, Weiyi Peng, Cara Haymaker, Sharia Hernandez, Luisa M. Solis, Vakul Mohanty, Ken Chen

Get full text

652 NT-I7 (efineptakin alfa), a long-acting IL-7, in combination with pembrolizumab improves T cell fitness in heavily pretreated subjects with gastrointestinal tumors by Cara Haymaker, Aung Naing, Minal Barve, Marya Chaney, Se Hwan Yang, Siyoung Lee, Byung Ha Lee, Sara Ferrando-Martinez, Hirva Mamdani, Richard D Kim, Meredith Pelster, Mohamed Derbala, Jack Goon, Samuel Darko, Julie Murphy, Lauren Gorelik, Allison Bierly

1534 Clinical activity of SD-101 with immune checkpoint inhibition (ICI) in metastatic uveal melanoma liver metastasis (MUM-LM) from the PERIO-01 Phase 1 trial by David Geller, Ashley Moody, Richard Carvajal, Cara Haymaker, Sunil Reddy, Jose Lutzky, Shailender Bhatia, Diwakar Davar, Bartosz Chmielowski, Theresa Medina, Eric Wehrenberg-Klee, Marlana Orloff, Rahul Sheth, Sapna P Patel, Robert Knight, Jason Laporte, Prajna Guha, Bryan Cox, Steven Katz, Paula Novelli, Joshua D Kuban, Ann-Marie Hulstine, Kamaneh Montazeri, Shaheer A Khan, Lindsay Thornton, Anthony Lucci, Vanessa Sarli, Salyna Meas, Chandra C Ghosh

Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial by Raquel Laza‐Briviesca, Alberto Cruz‐Bermúdez, Ernest Nadal, Amelia Insa, María del Rosario García‐Campelo, Gerardo Huidobro, Manuel Dómine, Margarita Majem, Delvys Rodríguez‐Abreu, Alex Martínez‐Martí, Javier De Castro Carpeño, Manuel Cobo, Guillermo López Vivanco, Edel Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Bartomeu Massuti, Marta Casarrubios, Belén Sierra‐Rodero, Carlos Tarín, Aránzazu García‐Grande, Cara Haymaker, Ignacio I. Wistuba, Atocha Romero, Fernando Franco, Mariano Provencio

Get full text

590 Clinical outcomes and translational analysis of DART S1609: the thyroid cancer cohort; PD-1+ PD-L1+ TIL correlated with favorable survival by Jianhua Zhang, Hong Chen, Cara Haymaker, Elad Sharon, Razelle Kurzrock, Young Kwang Chae, Jiexin Zhang, Jack Lee, Jianjun Zhang, Ignacio Wistuba, Megan Othus, Sarah Fenton, Cristina Rodriguez, Adedayo Onitilo, Ahmad Mattour, Igor Rybkin, Christine McLeod, Helen Chen, Christopher Ryan, Melissa Plets, Charles Blanke, Gheath Al-Atrash, Rajyalakshmi Luthra, Hye Sung Kim, Dzifa Y Duose, Liam Il-Young Chung, Sandip P Patel, Yichen Lu, Edwin Roger Parra, Lorena Isabel Gomez Bolanos, Caddie Laberiano Fernandez, Luisa Solis Soto, Ganiraju Manyam, Gabby Lopez